Natural Capsules Limited (NATCAPSUQ) — Board Meeting | 12 August 2026(3 announcements)

Natural Capsules Limited announced the appointment of Mr. K. H. Honneshaiah as Chief Operating Officer of its material unlisted subsidiary, Natural Biogenex Private Limited, effective August 12, 2026. The new COO brings 36 years of experience in regulated API and specialty operations across pharma, polymers, peptides, and CDMO sectors, with expertise in scaling plants and driving profitable growth. This leadership addition strengthens operational capabilities within the company's manufacturing and regulatory framework.

The board approved unaudited Q1 FY26 results, a preferential issue of up to 125,000 equity shares at ₹160 per share and 500,000 convertible warrants at ₹160 each to promoter Sunil L Mundra, and scheduled an extraordinary general meeting for September 9, 2026. The meeting ran from 3:30 PM to 6:00 PM on August 12, 2026.

Natural Capsules Limited held its 33rd Annual General Meeting on August 12, 2026 via video conference, adopting audited financial statements for FY2026, appointing directors to replace retiring members, and approving related party transactions with Natural Biogenex Private Limited. Shareholders participated remotely with quorum met by 34 members. The meeting concluded after 15 minutes of e-voting.